Complete Filing Data
Senti Biosciences Holdings, Inc. reported Stockholders Equity of $5.59 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Senti Biosciences Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue * | $22.0K | $0.00 | $2.0M | $3.3M | $2.3M |
| Net Income Loss | -$61.4M | -$52.8M | -$71.1M | -$58.2M | -$55.3M |
| Operating Income Loss | -$68.8M | -$61.0M | -$92.7M | -$62.1M | -$40.4M |
| Research And Development Expense | $37.6M | $34.4M | $32.2M | $28.1M | $22.0M |
| Other Nonoperating Income Expense | $800.0K | $200.0K | -$33.0K | -$32.0K | -$120.0K |
| Operating Expenses | $68.8M | $61.0M | $95.3M | $66.4M | $43.2M |
| General And Administrative Expense | $26.2M | $26.4M | $37.2M | $38.2M | $21.3M |
| Nonoperating Income Expense | $7.3M | $8.2M | $9.3M | $12.4M | -$14.9M |
| Comprehensive Income Net Of Tax | -$61.4M | -$52.8M | -$71.1M | -$58.2M | -$55.3M |
| Interest Income Expense Nonoperating Net | $927.0K | $948.0K | $2.9M | $1.7M | $11.0K |
| Revenue Not From Contract With Customer | $0.00 | $583.0K | $1.0M | $470.0K | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $0.00 | -$1.0K | $1.0K | $0.00 | |
| Asset Impairment Charges | $5.1M | $313.0K | $26.0M | $0.00 | $22.0K |
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | $0.00 | $12.3M | -$8.5M | ||
| Income Loss From Continuing Operations | -$52.8M | -$83.4M | -$49.7M | ||
| Income Loss From Continuing Operations Per Diluted Share | -$12.03 | -$18.80 | -$1.90 | ||
| Income Loss From Continuing Operations Per Basic Share | -$12.03 | -$18.80 | -$1.90 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $0.00 | $0.00 | $255.0K | $687.0K | $1.0M | $1.5M | $1.1M | $854.0K | $926.0K | $778.0K | |||||||
| Net Income Loss | -$18.1M | -$14.7M | -$14.1M | -$28.9M | -$11.2M | -$12.1M | -$71.1M | -$14.9M | -$18.7M | -$18.7M | -$58.2M | -$16.6M | -$11.6M | -$11.8M | -$11.4M | -$12.0M | -$21.0M | |
| Operating Income Loss | -$16.9M | -$16.8M | -$16.4M | -$15.2M | -$13.4M | -$16.3M | -$43.9M | -$15.2M | -$15.0M | -$14.7M | -$21.8M | -$11.8M | -$11.4M | -$9.0M | -$1.2K | |||
| Research And Development Expense | $10.5M | $10.0M | $9.3M | $8.7M | $9.2M | $8.8M | $9.1M | $6.9M | $7.1M | $6.5M | $9.2M | $7.6M | $5.4M | $5.2M | ||||
| Other Nonoperating Income Expense | $223.0K | $209.0K | $178.0K | -$11.0K | $6.0K | $0.00 | -$14.0K | -$4.0K | -$8.0K | $2.0K | $25.0K | -$54.0K | $21.0K | -$95.0K | ||||
| Operating Expenses | $16.9M | $16.8M | $16.4M | $15.2M | $13.4M | $16.3M | $44.2M | $16.1M | $16.3M | $16.5M | $23.1M | $12.9M | $12.5M | $9.8M | ||||
| General And Administrative Expense | $6.4M | $6.8M | $7.1M | $6.6M | $4.2M | $7.5M | $9.4M | $9.2M | $9.2M | $10.0M | $13.9M | $5.3M | $7.1M | $4.6M | ||||
| Nonoperating Income Expense | -$1.2M | $2.1M | $2.3M | -$13.7M | $2.2M | $4.2M | $7.3M | $938.0K | $1.1M | $445.0K | $10.2M | -$50.0K | $17.0K | -$3.0M | ||||
| Comprehensive Income Net Of Tax | -$18.1M | -$14.7M | -$14.1M | -$28.9M | -$11.2M | -$12.1M | -$14.9M | -$18.7M | -$18.7M | -$16.6M | -$11.6M | -$11.8M | -$11.4M | -$12.0M | ||||
| Interest Income Expense Nonoperating Net | $166.0K | $270.0K | $394.0K | $150.0K | $236.0K | $331.0K | $583.0K | $794.0K | $1.1M | $542.0K | $27.0K | $4.0K | $5.0K | $2.0K | ||||
| Revenue Not From Contract With Customer | $0.00 | $0.00 | $0.00 | $83.0K | $250.0K | $250.0K | $250.0K | $250.0K | $250.0K | $177.0K | $15.0K | |||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | -$3.0K | $2.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Asset Impairment Charges | $0.00 | $300.0K | $300.0K | $25.7M | $0.00 | $9.0K | ||||||||||||
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | $0.00 | $0.00 | $0.00 | $12.3M | $21.7M | -$4.4M | -$4.9M | -$8.5M | -$2.3M | |||||||||
| Income Loss From Continuing Operations | -$28.9M | -$11.2M | -$12.1M | -$83.4M | -$36.6M | -$14.3M | -$13.9M | -$49.7M | -$14.3M | |||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$6.31 | -$2.45 | -$0.26 | -$8.24 | -$3.22 | -$0.31 | -$0.33 | |||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$6.31 | -$2.45 | -$0.26 | -$8.24 | -$3.22 | -$0.31 | -$0.33 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $5.6M | $25.6M | $66.9M | $127.3M | -$111.5M | -$58.7M |
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $25.1M | $0.00 | $0.00 | $171.8M | $89.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $19.9M | $51.8M | $39.4M | $61.0M | $59.3M | $31.0M |
| Cash And Cash Equivalents At Carrying Value | $16.4M | $48.3M | $35.9M | $57.6M | $56.0M | |
| Retained Earnings Accumulated Deficit | -$358.6M | -$297.1M | -$244.3M | -$173.3M | -$115.1M | |
| Liabilities And Stockholders Equity | $51.2M | $97.8M | $119.5M | $180.8M | $96.7M | |
| Liabilities | $45.6M | $47.1M | $52.6M | $53.5M | $36.3M | |
| Assets | $51.2M | $97.8M | $119.5M | $180.8M | $96.7M | |
| Liabilities Current | $14.0M | $13.1M | $12.7M | $18.1M | $14.5M | |
| Assets Current | $23.3M | $59.0M | $71.2M | $102.6M | $60.2M | |
| Accounts Payable Current | $2.9M | $1.5M | $1.3M | $1.4M | $5.2M | |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | -$20.0K | -$207.0K | -$9.5M | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$31.9M | $12.4M | -$21.5M | $1.7M | $28.3M | |
| Restricted Cash | $3.5M | $3.5M | $3.5M | $3.4M | $3.3M | |
| Property Plant And Equipment Net | $12.9M | $21.3M | $25.3M | $51.4M | $12.4M | |
| Other Assets Noncurrent | $19.0K | $105.0K | $215.0K | $283.0K | $176.0K | |
| Operating Lease Right Of Use Asset | $11.5M | $13.9M | $16.3M | $18.4M | $20.7M | |
| Operating Lease Liability Noncurrent | $23.6M | $28.9M | $33.5M | $35.1M | $21.0M | |
| Operating Lease Liability Current | $5.3M | $4.6M | $4.0M | $2.0M | $1.7M | |
| Common Stock Value | $3.0K | $1.0K | $1.0K | $4.0K | $0.00 | |
| Preferred Stock Value | $0.00 | |||||
| Operating Lease Right Of Use Asset Amortization Expense | $2.0M | $1.9M | $2.5M | $2.2M | ||
| Accounts Payable And Other Accrued Liabilities Current | $5.4M | $6.4M | $5.9M | $12.6M | $5.3M | |
| Other Operating Activities Cash Flow Statement | $39.0K | $115.0K | $35.0K | $8.0K | $0.00 | |
| Gains Losses On Extinguishment Of Debt | $0.00 | $1.3M | $0.00 | |||
| Business Combination Contingent Consideration Liability Noncurrent | $0.00 | $20.0K | $227.0K | $0.00 | ||
| Temporary Equity Liquidation Preference | $0.00 | $147.6M | $0.00 | $0.00 | $163.8M | |
| Early Exercise Liability Noncurrent | $0.00 | $10.0K | $146.0K | $619.0K | ||
| Early Exercise Liability Current | $11.0K | $135.0K | $135.0K | $626.0K | ||
| Contract With Customer Liability Current | $43.0K | $0.00 | $0.00 | $799.0K | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $8.1M | $24.7M | $37.9M | $16.0M | $44.1M | $56.1M | $82.9M | $97.4M | $112.3M | $140.3M | $154.3M | -$121.8M | -$101.4M | -$90.6M | -$79.2M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $171.8M | $171.8M | $171.8M | $92.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.8M | $25.1M | $37.4M | $14.0M | $19.4M | $27.8M | $45.8M | $40.1M | $35.2M | $118.2M | $143.1M | $41.4M | $75.2M | $84.5M | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $12.2M | $21.6M | $33.8M | $10.5M | $15.9M | $23.7M | $39.4M | $36.8M | $31.6M | $114.9M | $139.8M | $38.1M | $73.7M | $82.9M | $0.00 | ||
| Retained Earnings Accumulated Deficit | -$344.1M | -$326.0M | -$311.2M | -$296.5M | -$267.7M | -$256.5M | -$225.6M | -$210.7M | -$192.0M | -$155.1M | -$138.4M | -$10.2M | -$6.5M | -$6.2M | -$1.2K | ||
| Liabilities And Stockholders Equity | $52.7M | $68.5M | $82.8M | $57.7M | $86.9M | $102.2M | $131.8M | $143.6M | $161.4M | $189.4M | $202.4M | $230.9M | $231.7M | $231.9M | $373.7K | ||
| Liabilities | $44.6M | $43.9M | $44.9M | $41.7M | $42.8M | $46.1M | $48.8M | $46.2M | $49.1M | $49.1M | $48.1M | $11.1M | $8.2M | $8.1M | $349.8K | ||
| Assets | $52.7M | $68.5M | $82.8M | $57.7M | $86.9M | $102.2M | $131.8M | $143.6M | $161.4M | $189.4M | $202.4M | $230.9M | $231.7M | $231.9M | $373.7K | ||
| Liabilities Current | $12.0M | $10.0M | $10.7M | $9.1M | $9.1M | $9.6M | $10.1M | $10.4M | $12.9M | $15.8M | $17.8M | $4.1M | $128.8K | $61.0K | |||
| Assets Current | $18.2M | $32.5M | $45.2M | $17.4M | $44.3M | $55.7M | $79.0M | $63.5M | $80.5M | $119.8M | $143.9M | $827.2K | $1.7M | $1.9M | |||
| Accounts Payable Current | $1.8M | $1.0M | $1.6M | $793.0K | $1.2M | $1.6M | $2.0M | $2.6M | $2.6M | $1.8M | $5.8M | $85.00 | $4.5K | $28.00 | |||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $0.00 | $0.00 | $0.00 | $0.00 | -$148.0K | -$59.0K | $99.0K | -$8.9M | $0.00 | $0.00 | $0.00 | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$14.5M | -$11.7M | -$25.8M | -$17.9M | |||||||||||||
| Restricted Cash | $3.5M | $3.5M | $3.5M | $3.6M | $3.5M | $4.0M | $6.4M | $3.3M | $3.6M | $3.3M | $3.3M | $3.3M | $1.5M | $1.5M | |||
| Property Plant And Equipment Net | $18.7M | $19.6M | $20.5M | $22.2M | $23.3M | $24.4M | $26.4M | $58.9M | $59.0M | $47.3M | $35.5M | ||||||
| Other Assets Noncurrent | $34.0K | $52.0K | $76.0K | $88.0K | $76.0K | $86.0K | $177.0K | $393.0K | $471.0K | $243.0K | $207.0K | ||||||
| Operating Lease Right Of Use Asset | $12.3M | $12.8M | $13.4M | $14.5M | $15.3M | $15.8M | $17.0M | $17.5M | $17.9M | $18.9M | $19.5M | ||||||
| Operating Lease Liability Noncurrent | $25.0M | $26.3M | $27.6M | $30.1M | $31.3M | $32.4M | $34.6M | $35.6M | $35.9M | $32.2M | $29.0M | ||||||
| Operating Lease Liability Current | $5.2M | $5.0M | $4.8M | $4.5M | $4.3M | $4.2M | $2.6M | $2.5M | $2.1M | $1.9M | $1.9M | ||||||
| Common Stock Value | $3.0K | $3.0K | $3.0K | $1.0K | $1.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Operating Lease Right Of Use Asset Amortization Expense | $477.0K | $462.0K | $770.0K | ||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | $5.1M | $3.6M | $3.8M | $3.0M | $2.6M | $2.7M | $4.0M | $5.0M | $7.6M | $11.9M | $9.1M | ||||||
| Other Operating Activities Cash Flow Statement | $38.0K | -$30.0K | |||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $1.3M | $0.00 | $0.00 | |||||||||||
| Business Combination Contingent Consideration Liability Noncurrent | $0.00 | $0.00 | $20.0K | $20.0K | $20.0K | $168.0K | $909.0K | $810.0K | |||||||||
| Temporary Equity Liquidation Preference | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Early Exercise Liability Noncurrent | $0.00 | $0.00 | $0.00 | $45.0K | $79.0K | $112.0K | $179.0K | $470.0K | |||||||||
| Early Exercise Liability Current | $45.0K | $78.0K | $111.0K | $135.0K | $135.0K | $135.0K | $135.0K | $297.0K | |||||||||
| Contract With Customer Liability Current | $0.00 | $164.0K | $407.0K | $99.0K | $833.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$43.4M | -$41.4M | -$52.4M | -$34.9M | -$34.6M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $559.0K | -$671.0K | $716.0K | $2.1M | $2.6M |
| Net Cash Provided By Used In Investing Activities | -$184.0K | $34.0K | $30.1M | -$82.0M | -$5.5M |
| Net Cash Provided By Used In Financing Activities | $11.8M | $53.7M | $779.0K | $118.6M | $68.4M |
| Increase Decrease In Accounts Payable | $1.7M | $797.0K | -$290.0K | $186.0K | -$617.0K |
| Share Based Compensation | $5.7M | $1.8M | $9.7M | $16.4M | $2.3M |
| Payments To Acquire Property Plant And Equipment | $196.0K | $26.0K | $12.0M | $41.4M | $5.5M |
| Increase Decrease In Operating Lease Liability | -$4.6M | -$4.0M | $484.0K | $14.1M | -$1.1M |
| Proceeds From Stock Options Exercised | $3.1M | $4.9M | $0.00 | $521.0K | $1.5M |
| Increase Decrease In Contract With Customer Liability | $0.00 | -$799.0K | -$1.0M | $1.8M | |
| Payments To Acquire Short Term Investments | $0.00 | $18.0M | $40.6M | $0.00 | |
| Increase Decrease In Deferred Sublease Income | -$356.0K | -$329.0K | $689.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$14.1M | -$11.7M | -$16.3M | -$10.1M | -$934.7K | $0.00 |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.1M | -$2.9M | -$1.8M | -$1.4M | $2.3K | $0.00 |
| Net Cash Provided By Used In Investing Activities | $0.00 | -$15.0K | -$9.5M | -$7.4M | -$230.0M | |
| Net Cash Provided By Used In Financing Activities | -$414.0K | $0.00 | -$35.0K | -$455.0K | $232.0M | |
| Increase Decrease In Accounts Payable | $357.0K | $389.0K | $280.0K | -$164.0K | $4.5K | $28.00 |
| Share Based Compensation | $1.2M | $1.3M | $3.8M | $661.0K | ||
| Payments To Acquire Property Plant And Equipment | $0.00 | $15.0K | $6.5M | $7.4M | ||
| Increase Decrease In Operating Lease Liability | -$1.1M | -$946.0K | $882.0K | $2.4M | ||
| Proceeds From Stock Options Exercised | $1.5M | $0.00 | $0.00 | $140.0K | ||
| Increase Decrease In Contract With Customer Liability | $0.00 | -$392.0K | -$453.0K | |||
| Payments To Acquire Short Term Investments | $0.00 | $18.0M | $0.00 | |||
| Increase Decrease In Deferred Sublease Income | -$147.0K | -$127.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.73 | -$12.03 | -$16.01 | -$2.23 | -$19.00 | |
| Temporary Equity Shares Outstanding | 0.00 | 21.2K | 0.00 | 0.00 | 19.5M | 11.5M |
| Weighted Average Number Of Shares Outstanding Basic | 22.5M | 4.6M | 4.4M | 26.1M | 2.9M | |
| Weighted Average Number Of Diluted Shares Outstanding | 22.5M | 4.6M | 4.4M | 26.1M | 2.9M | |
| Earnings Per Share Basic | $-2.73 | $-12.03 | $-16.01 | $-2.23 | $-19.00 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 30.9M | 4.8M | 4.6M | 44.1M | 3.0M | |
| Common Stock Shares Issued | 30.9M | 4.8M | 4.6M | 44.1M | 3.0M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 27.0M | |
| Preferred Stock Shares Outstanding | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | |||||
| Preferred Stock Shares Authorized | 0.00 | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | |||||
| Temporary Equity Shares Issued | 0.00 | 21.2K | 0.00 | 0.00 | 19.5M | |
| Temporary Equity Shares Authorized | 0.00 | 21.2K | 0.00 | 0.00 | 19.5M | |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.69 | -$0.56 | -$1.41 | -$6.31 | -$2.45 | -$2.65 | -$3.36 | -$4.22 | -$0.42 | -$0.38 | -$0.86 | -$3.72 | -$3.90 | -$4.13 | $0.00 | ||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.5M | 19.5M | 19.5M | 11.8M | ||
| Weighted Average Number Of Shares Outstanding Basic | 26.2M | 26.1M | 10.0M | 4.6M | 4.6M | 4.6M | 4.4M | 4.4M | 44.1M | 43.4M | 13.4M | 3.2M | 2.9M | 2.9M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 26.2M | 26.1M | 10.0M | 4.6M | 4.6M | 4.6M | 4.4M | 4.4M | 44.1M | 43.4M | 13.4M | 3.2M | 2.9M | 2.9M | |||
| Earnings Per Share Basic | $-0.69 | $-0.56 | $-1.41 | $-6.31 | $-2.45 | $-2.65 | $-3.36 | $-4.22 | $-0.42 | $-0.38 | $-0.86 | $-3.72 | $-3.90 | $-4.13 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 26.3M | 26.2M | 26.0M | 4.6M | 4.6M | 45.7M | 44.5M | 44.5M | 44.1M | 43.6M | 43.4M | ||||||
| Common Stock Shares Issued | 26.3M | 26.2M | 26.0M | 4.6M | 4.6M | 45.7M | 44.5M | 44.5M | 44.1M | 43.6M | 43.4M | ||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Temporary Equity Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Temporary Equity Shares Authorized | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.7M | $1.8M | $9.7M | $16.4M | $2.3M |
| Stock Issued During Period Value Vesting Of Early Exercise Of Stock Options | $11.0K | $135.0K | $136.0K | $965.0K | $84.0K |
| Depreciation | $3.6M | $3.8M | $3.6M | $1.4M | $769.0K |
| Additional Paid In Capital | $364.2M | $322.8M | $311.3M | $300.5M | $3.6M |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $15.0K | $8.2M | $4.4M | |
| Stock Issued During Period Value Stock Options Exercised | $496.0K | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.6M | $1.5M | $1.2M | $668.0K | -$776.0K | $1.3M | $409.0K | $3.4M | $3.8M | $2.3M | $9.2M | $661.0K | $626.0K | $562.0K | $372.0K |
| Stock Issued During Period Value Vesting Of Early Exercise Of Stock Options | $12.0K | $34.0K | $33.0K | $34.0K | $34.0K | $34.0K | $34.0K | $454.0K | $102.0K | $375.0K | $28.0K | $28.0K | |||
| Depreciation | $926.0K | $984.0K | $800.0K | $467.0K | $400.0K | $300.0K | $240.0K | $200.0K | $200.0K | ||||||
| Additional Paid In Capital | $352.2M | $350.6M | $349.1M | $312.5M | $311.8M | $312.5M | $308.6M | $308.1M | $304.3M | $295.4M | $292.7M | $0.00 | $0.00 | $0.00 | $24.4K |
| Capital Expenditures Incurred But Not Yet Paid | $170.0K | $0.00 | $4.8M | $8.9M | |||||||||||
| Stock Issued During Period Value Stock Options Exercised | $74.0K | $422.0K | $19.0K | $21.0K | $1.4M |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.